午后，CXO概念股再度上涨，康龙化成、皓元医药涨幅超过4%，药明康德大涨超过3%！医疗板块整体上涨，医疗ETF（512170）上涨超过1%。
据消息，美国顶级癌症治疗和研究机构希望城市（City of Hope）国家医疗中心在8月1日发布公告，称他们在临床前研究中开发出一种能够杀死所有实体恶性肿瘤（癌瘤）的靶向化疗药物AOH1996。
这一消息令人振奋，引发了广泛关注！然而专家表示，对于“超级抗癌药”AOH1996，虽然在细胞模型和动物模型的临床前研究中证实了其安全性和有效性，但是我们对于该药物是否能在后续的I/II/III期临床试验中达到所设定的研究终点，以及是否能表现出优异的安全性和有效性还是需要等待临床试验数据发布后才能作出判断。
CXO龙头药明康德也表示，这款药物的研究和开发还处于早期阶段，因此称其为“神药”还为时尚早。
随着该药物进入一期试验阶段，最终能否在临床上应用也将逐渐明朗，让我们以客观、理性的态度拭目以待。
据了解，经过动物模型验证药物可行性后，AOH1996已经进入了一期临床试验阶段，预计该阶段的试验将在2024年3月底前结束。
换句话说，大约在一年的时间内，我们就能看到这款药物在真实患者身上使用的数据了。
风险提示：医疗ETF（512170） passively tracks the CSI Medical Index, with the base date of December 31, 2004, and was published on October 31, 2014. The constituent stocks of the index are adjusted according to the index compilation rules in a timely manner.
The constituent stocks shown in the article are for demonstration purposes only and do not constitute any form of investment advice, nor do they represent the holding information and trading trends of any fund under the management company.
The risk levels evaluated by the fund manager for this fund and its connected funds are R3-medium risk and R4-medium to high risk, respectively, suitable for investors with suitability ratings of C3 and above, and C4 and above, respectively.
Any information mentioned in this article (including but not limited to individual stocks, comments, predictions, charts, indicators, theories, any form of statement, etc.) is for reference only. Investors are responsible for any independent investment decisions.
Also, any views, analysis, and predictions in this article do not constitute any form of investment advice to readers and do not assume any responsibility for any direct or indirect losses caused by the use of the content of this article.
Fund investment carries risks, and past performance of a fund does not guarantee its future performance. The performance of other funds managed by the fund manager does not constitute a guarantee of fund performance. Fund investment should be cautious.